Flavin adenine dinucleotide (FAD)-dependent glucose dehydrogenase (GDH) was identified and cloned from thermophilic filamentous fungi Talaromyces emersonii using the homology cloning method. A direct electron transfer bioanode composed of T. emersonii FAD-GDH and a single-walled carbon nanotube was produced. Enzymes from thermophilic microorganisms generally have low activity at ambient temperature; however, the T. emersonii FAD-GDH bioanode exhibits a large anodic current due to the enzymatic reaction (1 mA cm −2 ) at ambient temperature. Furthermore, the T. emersonii FAD-GDH bioanode worked at 70°C for 12 h. This is the first report of a bioanode with a glucose-catalyzing enzyme from a thermophilic microorganism that has potential for biosensor and biofuel cell applications. In addition, we demonstrate how the glycoforms of T. emersonii FAD-GDHs expressed by various hosts influence the electrochemical properties of the bioanode.
■ INTRODUCTION
Thermostable enzymes from thermophilic microorganisms display not only heat and chemical resistance but also excellent long-term storage tolerance. The application of thermostable enzymes is promising and has been reported by some researchers. 1−6 However, the application of a thermostable enzyme to catalyze glucose, which is one of the most important substrates in the fields of medicine, biochemistry, environmental science, fermentation, and agriculture, has not yet been reported. Talaromyces emersonii is a thermophilic filamentous fungus and is a natural saprophyte that inhabits soil and compost heaps. Highly specific thermostable enzyme cocktails produced by T. emersonii have been applied to the baking of bread. 7 However, T. emersonii does not secrete a glucosecatalyzing enzyme under conventional cultivation conditions. We have identified and cloned flavin adenine dinucleotide (FAD)-dependent glucose dehydrogenase (GDH) from T. emersonii using the homology cloning method. 8 Oxygen-insensitive FAD-GDH has attracted considerable attention over the past several years, and there are increasing reports of biosensors and biofuel cells that employ FAD-GDH. 9−24 FAD-GDH used in such biodevices is typically isolated from Aspergillus, 9−20 Glomerella, 21, 22 or Burkholderia; 23, 24 however, FAD-GDHs from these sources exhibit inadequate thermal stability and substrate selectivity, and they give rise to several practical problems. Consequently, an FAD-GDH suitable for biodevice applications such as biosensors and biofuel cells has not yet been identified. In this article, we present the characterization of a thermophilic T. emersonii FAD-GDH bioanode for biosensor and biofuel cell applications.
■ RESULTS AND DISCUSSION Characterization of T. emersonii FAD-GDHs Expressed by Various Hosts. Recombinant T. emersonii FAD-GDHs were expressed in the bacterium Escherichia coli (EcGDH) and the yeasts Pichia pastoris (PpGDH) and Saccharomyces cerevisiae (ScGDH) because the collection of FAD-GDHs from the original host is thought to be difficult. The recombinant proteins expressed in the yeasts have different glycoforms; thus, the FAD-GDHs have different molecular masses (EcGDH: 60 kDa; PpGDH: 90−150 kDa; ScGDH: 110−250 kDa). The FAD-GDHs used in this research are summarized in Table S1 in the Supporting Information, and the results of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) separation are shown in Figure 1 . Recombinant proteins expressed by the three hosts differ in their glycan chain amount, and their glycan chain lengths increase in the order ScGDH > PpGDH > EcGDH. Expression in prokaryotic E. coli, which cannot glycosylate proteins, is equivalent to removal of the glycosyl groups. The molecular mass of GDH without glycan chains is 60 kDa, which is the same as the molecular mass of EcGDH. The apparent mass of the glycan chains in PpGDH and ScGDH is between 50−183% and 83− 317% that of the peptide chain, respectively. Glycan chains are mainly composed of high mannose-type oligosaccharides that contain mannose and N-acetylglucosamine. 25, 26 These oligosaccharide chains connect to asparagine, threonine, and serine residues on the surface of GDH. The difference in the amount of glycan chains in PpGDH and ScGDH is attributed to S. cerevisiae-expressed proteins often being hyperglycosylated, where each oligosaccharide can contain more than 50 mannose residues. 25 The judicious choice of hosts is thus an unavoidable step in the utilization of enzymes by homology cloning.
Characterization of Bioanode with T. emersonii FAD-GDHs. The electrochemical performance of a bioanode is largely governed by the efficiency of electron transfer between the enzyme and the electrode (electron collector). The crystal structure of FAD-GDH from Aspergillus flavus has recently been solved: 27 The FAD cofactor in GDH is tightly and deeply embedded within a structurally rigid glycoprotein shell. Adopting the configuration for electron transfer is thought to be an unavoidable task in FAD-GDH. There are two approaches for electron transfer to occur. One is to utilize electron transfer mediators, which are often small and mobile agents such as hexacyanoferrate(III), 13 octacyanomalybdate, 12 osmium complexes, 10, 21, 22 phenothiazine, 11, 15 or menadione. 14 The problem with mediated electron transfer (MET) is that the mediators can leach out, reducing the sensitivity of this process and causing poisoning problems. Even if immobilized and polymeric mediators are adopted, the complicated process, which includes the preparation of an accommodating polymer matrix and the need to fine tune the hydrophobic mediator and hydrophilic enzyme, is not avoidable. The other approach is direct electron transfer (DET). We have previously reported that DET occurs between a single-walled carbon nanotube (SWNT) and FAD-GDH from A. oryzae, the amino acid sequence of which perfectly corresponds to that of A. flavus FAD-GDH. 9 Therefore, DET is expected to take place with the fabricated T. emersonii FAD-GDH bioanodes. To clearly evaluate the utility of these FAD-GDHs, a simple layer-bylayer process based on a SWNT and a plasma-polymerized thin film (PPF) 28, 29 was adopted, as shown in Figure 2 . The DET electrode has a sandwich-like structure of PPF/GDH/SWNT/ PPF/Au. The first PPF layer on the Au electrode acts as a scaffold for the formation of the SWNT layer. A SWNT layer cannot be obtained without the PPF layer being there first. The anionic surfactant sodium cholate disrupts the SWNT bundles into individual SWNT molecules. Figure 2A shows an atomic force microscopy (AFM) image of the surface of the SWNT layer (SWNT/PPF/Au) and shows that the SWNT network is formed by unbundled SWNT molecules. 29 Figure 2B shows an AFM image of the GDH immobilized surface (PPF/GDH/ SWNT/PPF/Au). As can be seen, GDH percolates into the SWNT and forms a SWNT−GDH complex, probably because the protein itself aids in stabilizing a SWNT dispersion.
Cyclic voltammograms (CVs) of bioanodes prepared with T. emersonii FAD-GDH expressed in three hosts (EcGDH, PpGDH, and ScGDH) at 20°C are shown in Figure 3A . Glucose concentration vs current plots using the CV data are shown in Figure S1 . The glucose-concentration-dependent current (GCDC) output due to the increase in the polarized potential increases steeply, and the oxidative current starts at around +0.1 V (onset potential). DET between FAD-GDH and a SWNT is represented by
FAD-GDH has only one enzyme-catalytic pathway (eqs 1 and 2). The GCDC at +0.4−0.8 V is not due to hydrogen peroxide because oxygen-insensitive FAD-GDH does not produce hydrogen peroxide. Therefore, the observation of a large GCDC at +0.4−0.8 V is evidence of DET between FAD-GDH and the SWNT. A quantum tunneling current due to an overpotential is the reason that GCDC did not appear at −0.45 V (redox potential of FAD) but did appear at +0.4−0.8 V. 9 The entire sequence of T. emersonii FAD-GDH is different from that of A. flavus FAD-GDH (64.2% sequence identity). However, both the structure and size of T. emersonii FAD-GDH were almost the same as those of A. flavus FAD-GDH, with a global model quality estimation score of 0.76, which suggests that the modeled structure is highly reliable. Three-dimensional structure modeling of T. emersonii FAD-GDH was performed based on the structure of A. flavus FAD-GDH 27 using the SWISS-MODEL server. 30 The overall FAD-GDH molecule is a 4.5 × 5.6 × 7.8 nm 3 globular structure. FAD is positioned 1.4 nm from the surface. A feasible scheme for this involves the side wall of the SWNT being plugged into the groove of FAD-GDH, as shown in Figure 3B , where the SWNT axis is embedded in the surface of the electrode and FAD-GDH has a groove into which a 1.2 nm diameter individual SWNT can enter. The individual SWNT can thus be close to a distance of 1.0 nm from the FAD positioned at the bottom of the groove in Figure 3B . We think that there is no possibility that the SWNT "docking" to FAD-GDH will block the substrate's access. There is space for the substrate (glucose) to gain access because a large GCDC is observed. Also, there is no possibility that the glycan shell will act like a spacer because the GCDC of the bioanode with a glycan-chain-rich enzyme is much larger than that using an enzyme with no glycan chain. Therefore, it is feasible that the current at +0.4−0.8 V is a tunneling current from FAD.
The markedly larger response of the PpGDH glycoprotein anode than that of the EcGDH deglycosylated protein is contrary to our expectation because (i) the activity of EcGDH is larger than that of PpGDH (Table S1 ) and (ii) the common strategy for MET is deglycosylation in order to shorten the distance between the electrode and the FAD cofactor in GDH. 10, 11, 22 This suggests that the strategy for controlling the glycan chain is different between DET and MET. It is possible that one role of the glycan chains is to stabilize the tertiary structure of the protein. The EcGDH deglycoprotein is less robust than the PpGDH glycoprotein; thus, EcGDH in close proximity to a SWNT may unfold and lose its activity. Conversely, the response of the ScGDH anode is markedly smaller than that of the PpGDH anode, possibly due to there being fewer enzymes undergoing DET on the ScGDH anode than on the PpGDH electrode because the thicker glycan shell on ScGDH prevents the SWNT from being in close proximity to the FAD cofactor.
Biofuel Cell. Next, the performance of the T. emersonii FAD-GDH bioanode was tested in a biofuel cell. A platinum electrode was used as the cathode to eliminate limitations from the cathode. Figure 4A shows the polarization curve and power output of a biofuel cell constructed from a PpGDH anode. The PpGDH anode can function at a high temperature (70°C). Furthermore, it works continuously for 12 h, as shown in Figure S2 . Tsujimura et al. 10 demonstrated that support by a hydrogel/mesoporous carbon matrix stabilizes the FAD-GDH structure, allowing functionality at temperatures up to 55°C to be achieved with a typical FAD-GDH bioanode. There is no effect of having a matrix support with the layer-by-layer immobilization procedure used in the present work. Therefore, this is typical of a thermostable enzyme from a thermophilic microorganism. If this system is combined with a biocathode that has a thermostable enzyme, 1 then a biofuel cell with longterm stability and high temperature resistance would be realized. Figure 4B shows the maximum output power of T. emersonii FAD-GDHs from various hosts as a function of temperature. The output power of the PpGDH bioanode is larger than that of the EcGDH bioanode at all temperatures, which corresponds to the CV data in Figure 3A . For the PpGDH bioanode, a higher temperature results in a higher output power. The output power vs temperature plot of the PpGDH anode is similar to the enzymatic activity vs temperature plot for free PpGDH. 8 In contrast, the output power of the EcGDH bioanode decreased when the temperature surpassed 40°C. The output power vs temperature plot for the EcGDH anode is different from the enzymatic activity vs temperature plot for free EcGDH, where the activity increased up to 60°C. The fragility of the tertiary structure in the EcGDH/SWNT complex is consistent with the CV data for the EcGDH/SWNT bioanode in Figure 3A .
For the ScGDH bioanode, although the output is smaller than that for the PpGDH anode, it increased with the temperature, which suggests that the glycan chains prevent the enzyme from unfolding and embedding in the SWNT under harsh conditions such as heating. PpGDH contains a suitable number of glycan chains, which allows DET to occur without unfolding. However, the thermostability of PpGDH is attributed not only to the presence of glycan chains but also to its sequence. This is supported by the decrease in the output power of the bioanode using normal FAD-GDH that has glycan chains when the temperature surpassed 40°C. Thus, the output power vs temperature profile for the glycosylated FAD-GDH anode from a nonthermophilic microorganism was similar to that for the EcGDH anode. It is thus concluded that PpGDH contains a suitable number of glycan chains, which allows the SWNT to closely approach FAD without PpGDH unfolding.
Biosensor. The performance of the PpGDH anode as a biosensor was evaluated. Amperometric measurements at a fixed potential are widely used to evaluate and analyze the performance of PpGDH anodes as a glucose biosensor. Figure  5A shows the steady-state amperometric response of the PpGDH anode at +0.6 V vs Ag/AgCl at 20°C. The current at +0.6 V is available for time-based measurement with a fixed potential. A sequential increase in the electrochemical signal with the increase of the glucose concentration at regular intervals is observed, and the glucose concentration range evaluated covers the physiological range. The response time was 6 s. The detection characteristics at very low concentrations (5−35 μM) are good, and the detection limit (signal/noise ratio = 2) was 5 μM (upper inset of Figure 5A ). The effects of interfering compounds such as ascorbic acid and uric acid on the sensing characteristics are negligible (bottom inset of Figure  5A ), which suggests that the PpGDH electrode can be used with physiological samples. Figure 5B shows a plot of current vs glucose concentration based on the data from Figure 5A . Table S2 shows the characteristics and performance of the biosensors with FAD-GDH from a thermophilic microorganism compared with those for other FAD-GDHs from nonthermophilic counterparts. The sensitivity determined from the slope for the PpGDH bioanode was 10 μA mM −1 cm −2 (r = 0.98 in the linear range of 0.005− 26 mM). It is significant that the biosensor with a thermophilic T. emersonii FAD-GDH bioanode can work at ambient temperature, similar to a normal FAD-GDH bioanode. It is also noteworthy that a wider dynamic range, from the detection limit to a glucose concentration indicative of diabetes, was observed compared to that of other FAD-GDH biosensors, which is a unique characteristic of biosensors with a thermophilic T. emersonii FAD-GDH anode (upper inset of Figure 5B ). Deviation from linearity is observed at high (>30 mM) glucose concentrations, a typical characteristic of the Michaelis−Menten model. This is a reaction-controlled step and can thus be analyzed using the Michaelis−Menten model. The bottom inset of Figure 5B 
where I is the steady-state current, I max is the maximum current under stationary substrate conditions, K m app denotes the apparent Michaelis constant, and C is the glucose concentration. I max and K m app were obtained by extrapolation of the plot. The large I max (0.43 mA cm −2 ) is indicative of a highly effective electronic contact. K m app for immobilized PpGDH was estimated to be 22 mM, which is significantly smaller than that for PpGDH in solution (K m = 337 mM). The operational stability and storage stability were confirmed. A current response greater than 90% was retained for 12 h. The response was retained over the period of 7 days by storing at room temperature. The results demonstrate several advantages of this electrode: (i) PpGDH is suitable for use in biosensor applications, despite its low affinity toward the substrate, i.e., large K m ; (ii) this low affinity toward the substrate means that a wide sensing dynamic range is obtained without the need to control diffusion, such as with a membrane; and (iii) despite being an enzyme from a thermophilic microorganism, PpGDH can be used at ambient temperature.
■ CONCLUSIONS
We have reported a bioanode with thermophilic filamentous fungi T. emersonii FAD-GDH for biosensor and biofuel cell applications. T. emersonii FAD-GDH was expressed in the bacterium E. coli and yeasts P. pastoris and S. cerevisiae and was obtained in different glycoforms. Although enzymes from thermophilic microorganisms typically have low activity at lower temperature, GCDC at an electrode incorporating a T. emersonii FAD-GDH anode was observed. The T. emersonii FAD-GDH (PpGDH) bioanode also functioned at 70°C for 12 h. It is possible that having a suitable amount of glycan chains at the FAD-GDH interface prevents electron transfer between FAD and the SWNT from being disturbed while also preventing denaturation of the enzyme at high temperature. This is the first report that a bioanode with a glucose-catalyzing enzyme from a thermophilic microorganism can be applied to biosensors and biofuel cells.
■ EXPERIMENTAL SECTION
Materials and Reagents. Distilled water, potassium dihydrogen phosphate, disodium hydrogen phosphate, Dglucose, L-ascorbic acid, uric acid, acetonitrile, and anionic surfactant sodium cholate (SC) were purchased from Kanto Chemical Co., Inc. (Tokyo, Japan). Single-walled carbon nanotubes (SWNT; 1.2−1.7 nm in diameter, 0.5 mm average length, Super Pure Tubes) were purchased from Nanointegris Inc. (Boisbrin, Canada). FAD-GDH (EC 1.1.5.9) from thermophilic T. emersonii was identified by our group. 8 Recombinant T. emersonii FAD-GDHs were expressed by the bacterium E. coli and yeasts P. pastoris 8 and S. cerevisiae. The S. cerevisiae INVSc1 strain and pYES2 expression vector were purchased from Thermo Fisher Scientific (Waltham, USA). In both yeast expression systems, the α-factor secretion signal was fused to FAD-GDH, and FAD-GDH was secreted into the culture media. FAD-GDH was purified by methods from our group. 8 Electrode Preparation. The electrochemical device as a working electrode was fabricated using a layer-by-layer process. The device was formed on sputtered Au. The width of the opening for the working electrode was 9 mm 2 . An ULVAC VEP-1000 plasma generator was used to deposit a 2 nm thick acetonitrile PPF layer onto Au. A SWNT/sodium cholate solution (1.5 mg mL −1 and 20 mg mL −1 , respectively) was dropped onto the PPF surface and dried in a vacuum oven. The thickness of the resulting sorted SWNT film was ca. 120 nm. Subsequently, the SWNT adsorbed surface was treated by acetonitrile plasma using the following parameters: power, 100 W; flow rate, 15 mL min −1 ; pressure, 0.6 Pa; and exposure time, 30 s (thickness < 1 nm). The role of PPF is surface modification and then layer formation (polymerization). The enzyme solution (3−10 mL) was then added by dropping an aliquot of enzyme in phosphate buffer (20 mM, pH 7.4) onto the film. All enzyme solutions for drop-casting contain 100 units. One hour later, the device was washed with water. Finally, the enzyme-adsorbed surface was overcoated with a 6 nm thick acetonitrile PPF layer (second layer). The deposition parameters were as follows: power; 150 W, pressure; 0.6 Pa, and exposure time; 150 s. The devices were stored in a refrigerator at 4°C until use.
Measurements. AFM was conducted in tapping mode in an air atmosphere using a NanoScope V Dimension Icon stage system produced by Bruker AXS GmbH (Karlsruhe, Germany). The scanning rate was 0.33−1.0 Hz. Electrochemical measurements were performed with an electrochemical analyzer (ALS Instruments, 701A, West Lafayette, IN) using a three-electrode configuration. Reference (Ag/AgCl, RE-1C) and counter (platinum wire, cathode) electrodes were purchased from Bioanalytical Systems Inc. Electrochemical measurements were conducted in a 5 mL vessel at ambient temperature (20°C) using phosphate buffer (20 mM, pH 7.4) as the supporting electrolyte. To prepare samples at designated concentrations, stock glucose solutions of 2.5, 25, or 250 mM were successively added. 
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